Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Maxwell

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
European Urology|October 29, 2021
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate CancerDaniel J Lee, Ryan Hausler, Anh N Le, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct genomic and immunologic tumor evolution in germline <i>TP53</i>-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.
European Urology Oncology|November 5, 2023
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate CancerJohn K Lin, Caleb M Hearn, Emily Getzen, et al.
Nature Communications|May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.
HGG Advances|October 1, 2023
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variantsKelvin C de Andrade, Natasha T Strande, Jung Kim, et al.
Nature Communications|August 24, 2017
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Gastric epithelium from <i>BRCA1</i> and <i>BRCA2</i> carriers harbors increased double-stranded DNA damage and augmented growthKole H Buckley, Michaela E Dungan, Kevin Dinh, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
Nature Communications|November 7, 2022
Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific driversJennifer B Shah, Dana Pueschl, Bradley Wubbenhorst, et al.
Cell Reports|January 22, 2026
Immune gene diversity and STING1 variants in shaping cancer immunity across different genetic ancestry populationsXiaowen Hu, Jie Huang, Jiao Yuan, et al.
American Journal of Human Genetics|May 7, 2016
Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerKara N Maxwell, Steven N Hart, Joseph Vijai, et al.
European Urology|October 29, 2021
Association of Inherited Mutations in DNA Repair Genes with Localized Prostate CancerDaniel J Lee, Ryan Hausler, Anh N Le, et al.
Biorxiv : the Preprint Server for Biology|April 15, 2024
Distinct genomic and immunologic tumor evolution in germline <i>TP53</i>-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.
European Urology Oncology|November 5, 2023
Validation of Biomechanical Computed Tomography for Fracture Risk Classification in Metastatic Hormone-sensitive Prostate CancerJohn K Lin, Caleb M Hearn, Emily Getzen, et al.
Nature Communications|May 21, 2026
Distinct genomic and immunologic tumor evolution in germline TP53-driven breast cancersNabamita Boruah, David Hoyos, Renyta Moses, et al.
HGG Advances|October 1, 2023
Genome-first approach of the prevalence and cancer phenotypes of pathogenic or likely pathogenic germline TP53 variantsKelvin C de Andrade, Natasha T Strande, Jung Kim, et al.
Nature Communications|August 24, 2017
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriersKara N Maxwell, Bradley Wubbenhorst, Brandon M Wenz, et al.
Biorxiv : the Preprint Server for Biology|November 19, 2025
Gastric epithelium from <i>BRCA1</i> and <i>BRCA2</i> carriers harbors increased double-stranded DNA damage and augmented growthKole H Buckley, Michaela E Dungan, Kevin Dinh, et al.
Pageof 20